Commits Rs 1000 crore to power AI-driven scaling, innovation, and strengthen healthtech penetration
Lytus Technologies has announced the completion of its acquisition of Blod.in, on-demand blood component management and logistics platform (powered by advanced AI and machine learning algorithms) – currently operational in Chennai and soon to be available nationally.
This partnership will ensure timely access to life-saving blood products and enhancing the overall efficiency of the healthcare ecosystem. Over the last twelve months, Blod.in scaled rapidly, growing from 30 to 140 hospitals with a 20 per cent month-on-month growth trajectory. Now operating in Chennai, it plans to expand to 100 more hospitals and 15+ blood banks, with further growth in Bengaluru, Mumbai, and Hyderabad and other cities in the next phase. Blod.in’s AI-driven technology will soon expand to global markets like the U.S. and UAE, optimising inventory, minimising wastage, and ensuring timely blood availability for patients, hospitals, and blood banks.
Lytus Technologies has secured and committed Rs 1000 crores as growth capital over the next three years to scale operations both organically and inorganically, expand its digital ecosystem, and advance HealthTech innovations. A significant portion of this investment is dedicated to advancing AI- and ML-powered solutions across Lytus HealthTech, including Blod.in’s AI engine, which optimises blood inventory forecasting, real-time supply-demand mapping, and last-mile routing intelligence for temperature-sensitive deliveries.
Dharmesh Pandya, CEO of Lytus Technologies, highlighted the strategic importance of this launch in Lytus’ long-term vision. He said, “Healthcare presents a powerful intersection of business growth and societal impact. At Lytus HealthTech, we are committed to building scalable solutions that seamlessly integrate Advanced AI, ML, and Agentic AI to transform the future of blood and medical logistics. Our focus is on improving access, streamlining workflows, and delivering better patient outcomes across India. Our strong revenue trajectory reflects our ability to execute on vision and capitalise on emerging market opportunities. The Rs 1000 crores financing empowers us to deepen investments in high-growth sectors while maintaining operational agility. We remain focused on sustainable growth, investing in next-generation technologies to elevate both customer experience and shareholder value”
Sai Guna Ranjan Puranam, COO, Lytus HealthTech, stated, “We are not just building a digital-first platform, we are building a community of healthcare providers, connected by trust, technology, and the shared mission to save lives. Our AI-first model enables proactive collaboration, not reactive firefighting ensuring every patient, every hospital, and every unit of blood is accounted for with precision and care. We are uniquely positioned to solve critical challenges in patient care and medical logistics.”
- Advertisement -